Back to top

J.P. Morgan Reaffirms Their Buy Rating on TG Therapeutics (TGTX)

J.P. Morgan analyst Brian Cheng maintained a Buy rating on TG Therapeutics yesterday and set a price target of $72.00. The company’s shares closed ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

TG Therapeutics, Inc. (TGTX)